Geneva [Switzerland], January 11 (ANI/PRNewswire): SELUTION SLR™, MedAlliance's novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of coronary de novo lesions.
The plea stated that at present cardiac stents or coronary stents are allowed to be manufactured or imported and sold, without or with negligible supporting clinical study or data, and merely based on predicate (device or literature), submitted by the manufacturer or importer.
New Delhi [India], January 9 (ANI/NewsVoir): Like every year, this year also the world's largest entrepreneurial train journey, Jagriti Yatra is going on a national odyssey with the resolve of "building India through enterprise". Since this year's yatra is being organised in Amrit Kaal, it h
Daily covid tally could reach the Japanese government's earlier projection of 4,50,000 nationwide, according to Toho University Professor Tateda Kazuhiro, who is on the government's coronavirus advisory panel.
According to an internal document of the Chinese CDC, 248 million people were infected by the coronavirus between December 1 and 20. As of now, the total number of Covid infections has reached 665 million globally while 6.69 million people have died, Asia Times reported.
India saw a slight increase in Covid infections on Thursday as it witnessed 188 new cases in the last 24 hours on Thursday, the Union Ministry of Health and Family Welfare said.
As the Covid-19 pandemic showed, potentially dangerous new viruses can begin to spread in the population well before the global public health surveillance system can detect them.
The national capital logged 6 new Covid cases in the last 24 hours, with the case positivity rate at 0.13 per cent, stated a bulletin issued by the Delhi Health Department on Wednesday.
The Union Ministry of Health and Family Welfare on Wednesday said that the country recorded a total of 175 new cases of Coronavirus infection in the last 24 hours.
Amid the exponential rise in COVID-19 cases in China, the pharmaceutical industries are finding it difficult to cope with the high demand for medicines after the Xi Jinping-led government announced relaxations in its zero-Covid policy.